Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$124.46
-5.4%
$131.18
$99.71
$141.23
$215.85B0.75.90 million shs10.78 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$451.58
-8.7%
$545.18
$364.17
$616.00
$160.84B1.551.54 million shs4.11 million shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$1.00
-2.0%
$1.65
$0.96
$5.15
$34.06M1.55409,192 shs313,927 shs
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$0.46
+21.1%
$1.59
$0.34
$29.00
$1.52M1.542.22 million shs122.34 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-5.40%-4.85%-9.60%+9.34%+11.81%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-8.70%-8.19%-20.50%-15.64%+17.78%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-1.96%-12.28%-39.39%-57.08%-38.65%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
+21.15%+18.89%-53.54%-90.21%-95.47%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9588 of 5 stars
3.44.04.24.53.52.52.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.7654 of 5 stars
4.33.00.04.03.62.51.9
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.4365 of 5 stars
3.73.00.04.11.20.80.0
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.6619 of 5 stars
0.04.00.00.02.20.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.9410.83% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$611.8635.49% Upside
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.33
Buy$4.00300.00% Upside
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest RMTI, RSLS, ABT, and ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/24/2025
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$7.00 ➝ $3.00
3/18/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$707.00 ➝ $600.00
3/17/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/17/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$666.00 ➝ $605.00
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $154.00
1/28/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
1/27/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$149.00 ➝ $158.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$550.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$490.00 ➝ $530.00
(Data available from 4/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.15$5.36 per share23.22$22.36 per share5.57
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B19.26$5.95 per share75.93$46.41 per share9.73
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$101.49M0.34$0.01 per share92.73$0.75 per share1.33
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$8.18M0.19N/AN/A$29.49 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6516.2721.722.5231.95%20.74%11.19%4/16/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.4170.4559.185.8527.81%14.55%12.88%4/22/2025 (Estimated)
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$8.44M-$0.02N/AN/AN/A-1.25%8.55%3.80%5/13/2025 (Estimated)
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
-$11.39MN/A0.00N/A-86.36%-179.83%-91.48%N/A

Latest RMTI, RSLS, ABT, and ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/22/2025N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71N/AN/AN/A$2.19 billionN/A
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
4/4/2025Q4 2024
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/A-$1.89N/A-$1.89N/AN/A
3/20/2025Q4 2024
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.02-$0.02-$0.04-$0.02$23.65 million$24.67 million
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.90%+7.17%30.85%54 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
N/AN/AN/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/AN/AN/AN/AN/A

Latest RMTI, RSLS, ABT, and ISRG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.07
3.22
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
0.33
2.41
2.00
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/A
1.33
0.60

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
23.31%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
22.06%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.70%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
1.90%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
12,100356.18 million352.97 millionOptionable
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
30034.06 million31.71 millionOptionable
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
503.31 million729,000Not Optionable

Recent News About These Companies

ReShape Lifesciences signs distribution agreement with Liaison Medical
ReShape Lifesciences 2.6M share Secondary priced at $2.33
ReShape Lifesciences granted key IP in Israel
Learn to Evaluate (RSLS) using the Charts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$124.46 -7.17 (-5.45%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$125.24 +0.78 (+0.63%)
As of 04/4/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$451.58 -43.03 (-8.70%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$451.95 +0.37 (+0.08%)
As of 04/4/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Rockwell Medical stock logo

Rockwell Medical NASDAQ:RMTI

$1.00 -0.02 (-1.96%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$1.00 +0.00 (+0.40%)
As of 04/4/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

ReShape Lifesciences stock logo

ReShape Lifesciences NASDAQ:RSLS

$0.46 +0.08 (+21.15%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$0.42 -0.05 (-9.78%)
As of 04/4/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California.